Development and validation of a simple reversed-phase HPLC method for the determination of camptothecin in animal organs following administration in solid lipid nanoparticles

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 880, Issue 1, 2012, Pages 100-107

  Martins, Susana M ^a   Wendling, Thierry ^a   Gonçalves, Virgínia M F ^b   Sarmento, Bruno ^a,b   Ferreira, Domingos C ^a  

^a UNIVERSITY OF PORTO   (Portugal)

^b UNIVERSITY INSTITUTE OF HEALTH SCIENCES IUCS   (Portugal)

Author keywords

Anticancer; Camptothecin (CPT); Fluorescence detector; In vivo; RP HPLC; Solid lipid nanoparticles (SLN)

Indexed keywords

ANTICANCER; CAMPTOTHECINS; FLUORESCENCE DETECTOR; IN VIVO; RP-HPLC; SOLID LIPID NANOPARTICLES (SLN);

ACETONITRILE; BODY FLUIDS; CHROMATOGRAPHY; DETECTORS; FLUORESCENCE; NANOPARTICLES; RATS;

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CAMPTOTHECIN; SOLID LIPID NANOPARTICLE;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CALIBRATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG RETENTION; DRUG STABILITY; FLOW RATE; FLUORESCENCE; HEART; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KIDNEY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LIVER; LUNG; MALE; NONHUMAN; PARTICLE SIZE; PH; PHARMACOKINETICS; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; RAT; ROOM TEMPERATURE; SPLEEN; ZETA POTENTIAL;

ANALYSIS OF VARIANCE; ANIMALS; CAMPTOTHECIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DRUG DELIVERY SYSTEMS; DRUG STABILITY; LIMIT OF DETECTION; LINEAR MODELS; MALE; NANOPARTICLES; PALMITATES; POLYSORBATES; RATS; RATS, WISTAR; REPRODUCIBILITY OF RESULTS; TISSUE DISTRIBUTION;

ANIMALIA; RATTUS;

EID: 84855188882     PISSN: 15700232     EISSN: 1873376X     Source Type: Journal    
DOI: 10.1016/j.jchromb.2011.11.023     Document Type: Article

References (36)

1. Giovanella B.C., Hinz H.R., Kozielski A.J., Stehlin J.S., Silber R., Potmesil M. Cancer Res. 1991, 51:3052.
2. Potmesil M. Cancer Res. 1994, 54:1431.
3. Storm P.B., Moriarity J.L., Tyler B., Burger P.C., Brem H., Weingart J. J. Neurooncol. 2002, 56:209.
4. Bokstein F., Shpigel S., Blumenthal D.T. Cancer 2008, 112:2267.
5. Puduvalli V.K., Giglio P., Groves M.D., Hess K.R., Gilbert M.R., Mahankali S., Jackson E.F., Levin V.A., Conrad C.A., Hsu S.H., Colman H., de Groot J.F., Ritterhouse M.G., Ictech S.E., Yung W.K. Neuro Oncol. 2008, 10:216.
6. Santisteban M., Buckner J.C., Reid J.M., Wu W., Scheithauer B.W., Ames M.M., Felten S.J., Nikcevich D.A., Wiesenfeld M., Jaeckle K.A., Galanis E. J. Neurooncol. 2009, 92:165.
7. Vredenburgh J.J., Desjardins A., Herndon J.E., Dowell J.M., Reardon D.A., Quinn J.A., Rich J.N., Sathornsumetee S., Gururangan S., Wagner M., Bigner D.D., Friedman A.H., Friedman H.S. Clin. Cancer Res. 2007, 13:1253.
8. Cirpanli Y., Allard E., Passirani C., Bilensoy E., Lemaire L., Calis S., Benoit J.P. Int. J. Pharm. 2011, 403:201.
9. Rivory L.P., Robert J. Pharmacol. Ther. 1995, 68:269.
10. Giovanella B.C., Harris N., Mendoza J., Cao Z., Liehr J., Stehlin J.S. Ann. N. Y. Acad. Sci. 2000, 922:27.
11. Joshi M.D., Muller R.H. Eur. J. Pharm. Biopharm. 2009, 71:161.
12. Souto E.B., Muller R.H. Handb. Exp. Pharmacol. 2010, 115.
13. Yang S.C., Zhu J.B. Drug Dev. Ind. Pharm. 2002, 28:265.
14. Yang S., Zhu J., Lu Y., Liang B., Yang C. Pharm. Res. 1999, 16:751.
15. Yang S.C., Lu L.F., Cai Y., Zhu J.B., Liang B.W., Yang C.Z. J. Control Release 1999, 59:299.
16. Liu X., Wang Y., Vardeman D., Cao Z., Giovanella B. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2008, 867:84.
17. Ahmed F., Vyas V., Saleem A., Li X.G., Zamek R., Cornfield A., Haluska P., Ibrahim N., Rubin E.H., Gupta E. J. Chromatogr. B Biomed. Sci. Appl. 1998, 707:227.
18. Beijnen J.H., Rosing H., ten Bokkel Huinink W.W., Pinedo H.M. J. Chromatogr. 1993, 617:111.
19. Supko J.G., Malspeis L. J. Liq. Chromatogr. 1991, 14:1779.
20. Loh J.P., Ahmed A.E. J. Chromatogr. 1990, 530:367.
21. Yang X., Hu Z., Chan S.Y., Goh B.C., Duan W., Chan E., Zhou S. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2005, 821:221.
22. Pace S., Capocasa F., Tallarico C., Frapolli R., Zucchetti M., Longo A. J. Pharm. Biomed. Anal. 2009, 50:507.
23. Baylatry M.T., Joly A.C., Pelage J.P., Bengrine-Lefevre L., Prugnaud J.L., Laurent A., Fernandez C. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2010, 878:738.
24. Owens T.S., Dodds H., Fricke K., Hanna S.K., Crews K.R. J. Chromatogr. B 2003, 788:65.
25. Upreti V.V., Mamidi R.N., Katneni K., Srinivas N.R. Biomed. Chromatogr. 2003, 17:385.
26. Tsakalozou E., Horn J., Leggas M. Biomed. Chromatogr. 2010, 24:1045.
27. Ma J., Liu C.L., Zhu P.L., Jia Z.P., Xu L.T., Wang R. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2002, 772:197.
28. ICH guideline Q2(R1): Validation of Analytical Procedures: Text and Methodology (2005).
29. Fox M.E., Guillaudeu S., Frechet J.M., Jerger K., Macaraeg N., Szoka F.C. Mol. Pharm. 2009, 6:1562.
30. Nomura T., Koreeda N., Yamashita F., Takakura Y., Hashida M. Pharm. Res. 1998, 15:128.
31. Lockman P.R., Koziara J.M., Mumper R.J., Allen D.D. J. Drug Target. 2004, 12:635.
32. Kedmi R., Ben-Arie N., Peer D. Biomaterials 2010, 31:6867.
33. Guidance for Industry Bioanalytical Method Validation, US Department of Health and Human Services, FDA, CDER, CVM, Available from: , 2001. http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm070107.pdf.
34. Jain A.K., Swarnakar N.K., Das M., Godugu C., Singh R.P., Rao P.R., Jain S. Mol. Pharm. 2011, 8:1140.
35. Davis M.E., Chen Z.G., Shin D.M. Nat. Rev. Drug Discov. 2008, 7:771.
36. Torchilin V.P. Handb. Exp. Pharmacol. 2010, 3.